Of note, interferon regulatory factor 5 (IRF5) is one of the confirmed downregulated transcripts, and polymorphisms in this gene has been associated to the risk of developing MS in last genome-wide association analysis, performed by the International Multiple Sclerosis Genetics Consortium, as well as in replication studies in Spanish cohorts [34,35]. The gene discussed is IRF5; the disease is myeloid sarcoma.